Clinical significance of Tmax [Regulatives / Guidelines]

posted by M.tareq  – 2017-10-12 07:53 (1202 d 12:32 ago) – Posting: # 17890
Views: 4,418

Dear all ,

I have a question about Tmax from clinical perspective.

According to EMA guidance:
"A statistical evaluation of tmax is not required. However, if rapid release is claimed to be clinically relevant and of importance for onset of action or is related to adverse events, there should be no apparent difference in median tmax and its variability between test and reference product."

If a fast disintegrating tab has a tmax earlier than the conventional release, does it prove that it has an earlier onset of action?

Thanks in advance and Best regards

Complete thread:

 Admin contact
21,315 posts in 4,446 threads, 1,489 registered users;
online 2 (0 registered, 2 guests [including 1 identified bots]).
Forum time: Tuesday 19:25 CET (Europe/Vienna)

Any one who considers arithmetical methods
of producing random digits is, of course,
in a state of sin.    John von Neumann

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz